You are viewing a free limited preview of Nodality, Inc.
Get Full Access To This Report 
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
Nodality, Inc. is a privately-held, venture capital backed biotechnology company that engages in the discovery and development of personal diagnostics characterizing cell signaling pathways in a defined cellular sub-populations of malignant and normal cells from individual patients. It mainly focuses on hematological malignancies and autoimmune disorders. Founded in 2003, Nodality, Inc. is headquartered in San Francisco, California.
| Company Tags: | PE Backed VC Backed |
| Year Founded: | 2003 |
| Fiscal Year End: | 12/31 |
| 1YR Revenue Growth Rate: | View % |
| City: | South San Francisco |
| State/Province: | California |
| Country: | United States |
| Phone: | View |
| Fax: | View |
| Website: | www.nodalityinc.com |
| Founders: | Garry P. Nolan Omar D. Perez |
| Healthcare > Clinical Research Services > Other Clinical Research Services |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Export All Nodality, Inc. Financials To Excel
$99 Single Company AccessInstant Full Site-Wide Access| Financial Notes: | |
| * | Nodality, Inc. fiscal year end: 12/31 |
Export All Nodality, Inc. Financials To Excel
$99 Single Company AccessInstant Full Site-Wide AccessNodality, Inc. Revenues ($ MM): |
Export Financials to Excel
$99 Single Company AccessInstant Full Site-Wide Access| Date | Status | Target | Buyer | Deal Type | Price | |
| Details | Feb. 2008 | Completed | View | View | Acquisition Leveraged Buyout (LBO) | View |
Missing a deal? Tell us about it! tips@privco.com
$99 Single Company AccessInstant Full Site-Wide Access| Date | Investor | Round | Investor Type | |
| Aug. 2006 | View | A | Private Equity & Venture Capital | |
| Aug. 2006 | View | A | Private Equity | |
| Details | Total Round A View | |||
| Mar. 2008 | View | Other | Private Equity & Venture Capital | |
| Details | Total Round Other View | |||
| Oct. 2009 | View | B | Private Equity & Venture Capital | |
| Oct. 2009 | View | B | Venture Capital | |
| Oct. 2009 | View | B | Hedge Fund | |
| Details | Total Round B View | |||
| Dec. 2009 | View | C | Private Equity & Venture Capital | |
| Dec. 2009 | View | C | Hedge Fund | |
| Details | Total Round C View | |||
| Mar. 2010 | View | Other | Private Equity | |
| Mar. 2010 | View | Other | Private Equity & Venture Capital | |
| Mar. 2010 | View | Other | Hedge Fund | |
| Mar. 2010 | View | Other | Venture Capital | |
| Details | Total Round Other View | |||
| Aug. 2011 | View | Debt Funding | Venture Capital | |
| Details | Total Round Debt Funding View | |||
| Total of Funding Shown Above View | ||||
Missing a deal? Tell us about it! tips@privco.com
$99 Single Company AccessInstant Full Site-Wide AccessBusiness Overview
Nodality is a biotechnology research and development firm that focuses on improving cancer treatment through Single Cell Network Profiling. Nodality’s proprietary technology is based on research first performed by Gary Nolan at Stanford University. Nodality licenses the technology from Stanford. Nodality has taken the original research and developed an advanced solution that characterizes individual cancer cells using advanced flow cytometry. The main health areas that Nodality targets are hematological malignancies and autoimmune disorders
Revenue Model
Nodality generates revenue through partnerships with pharmaceutical and biotechnology companies to help them develop new clinical tests and drugs. The Nodality technology can be licensed to help commercialize drugs or improve the efficiency and effectiveness of clinical tests. Nodality’s Single Cell Network Profiling technology has applications in preclinical, clinical, and commercial therapeutics.… Continue Reading →
$99 Single Company AccessInstant Full Site-Wide Access|
Get Full Access To This Report
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
PrivCo is the authority for financial & business data on major private companies, including:
| Private Companies | 209,169 |
| Private Investors | 12,026 |
| Private M&A Deals | 43,190 |
| VC/Funding Rounds | 36,107 |
| Total Data Points | 95,786,176 |
You are viewing a free limited preview of Nodality, Inc.
PrivCo is the premier source for business and financial data on major, non-publicly traded corporations, including family owned, private equity owned, venture backed, and international unlisted companies. Click here to learn more.
PDF VERSION: Download Company Report in PDF Format
Full Online Report